Scientists are rapidly focused on retatrutide, a innovative treatment from Eli Lilly, as a significant breakthrough in body management. Unlike many existing approaches, retatrutide is a double -action agonist targeting equally GLP-1 and GIP, hormones that influence hunger and blood glucose contr… Read More